RBC Capital lowered the firm’s price target on Avantor (AVTR) to $20 from $24 and keeps an Outperform rating on the shares. The stock sold off about 20% after Q1 results, and the firm remains cautious on the near-term setup for the sector, the analyst tells investors in a research note. For Avantor, the quarter included a slowdown in purchasing from certain academic customers, lower demand from a continued decline in biotech funding, and weaker China demand, RBC adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: